Patents by Inventor Antoine Danchin

Antoine Danchin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds for treating diseases associated with a mitochondrial dysfunction
    Patent number: 11684611
    Abstract: The present invention relates to a compound of the following formula (A): or a pharmaceutically acceptable salt or hydrate thereof, for use in the prevention or treatment of a disease associated with a mitochondrial dysfunction.
    Type: Grant
    Filed: November 2, 2020
    Date of Patent: June 27, 2023
    Assignee: Amabiotics
    Inventors: Antoine Danchin, Agnieszka Sekowska, Patrice Garnier
  • COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASES
    Publication number: 20230040247
    Abstract: The present invention relates to a compound of the following formula (I): or a pharmaceutically acceptable salt or hydrate thereof, for use in the prevention or treatment of a neurodegenerative disease selected from the group consisting of a-synucleinopathy, in particular Lewy body disease, Huntington's disease, frontotemporal neurocognitive disorder, and amyotrophic lateral sclerosis in an individual.
    Type: Application
    Filed: September 12, 2020
    Publication date: February 9, 2023
    Inventors: Nicole McKnight, Patricia Richard, Xavier Maniere, Antoine Danchin, Patrice Garnier
  • COMPOUNDS FOR TREATING ALZHEIMER'S DISEASE
    Publication number: 20210052589
    Abstract: The present invention relates to a compound of the following formula (I): (I) or a pharmaceutically acceptable salt or hydrate thereof, for use in the prevention or treatment of Alzheimer's disease in an individual.
    Type: Application
    Filed: March 7, 2019
    Publication date: February 25, 2021
    Applicant: Amabiotics
    Inventors: Patrice Garnier, Antoine Danchin
  • Compounds for Treating Diseases Associated with a Mitochondrial Dysfunction
    Publication number: 20210046056
    Abstract: The present invention relates to a compound of the following formula (A): or a pharmaceutically acceptable salt or hydrate thereof, for use in the prevention or treatment of a disease associated with a mitochondrial dysfunction.
    Type: Application
    Filed: November 2, 2020
    Publication date: February 18, 2021
    Applicant: Amabiotics
    Inventors: Antoine Danchin, Agnieszka Sekowska, Patrice Garnier
  • Compounds for treating diseases associated with a mitochondrial dysfunction
    Patent number: 10857135
    Abstract: The present invention relates to a compound of the following formula (A): or a pharmaceutically acceptable salt or hydrate thereof, for use in the prevention or treatment of a disease associated with a mitochondrial dysfunction.
    Type: Grant
    Filed: August 30, 2017
    Date of Patent: December 8, 2020
    Assignee: AMABIOTICS
    Inventors: Antoine Danchin, Agnieszka Sekowska, Patrice Garnier
  • COMPOUNDS FOR TREATING DISEASES ASSOCIATED WITH A MITOCHONDRIAL DYSFUNCTION
    Publication number: 20190224174
    Abstract: The present invention relates to a compound of the following formula (A): or a pharmaceutically acceptable salt or hydrate thereof, for use in the prevention or treatment of a disease associated with a mitochondrial dysfunction.
    Type: Application
    Filed: August 30, 2017
    Publication date: July 25, 2019
    Inventors: ANTOINE DANCHIN, AGNIESZKA SEKOWSKA, PATRICE GARNIER
  • Cosmetic use of Queuine
    Patent number: 9610236
    Abstract: The present invention relates to the cosmetic use of queuine, in particular to combat aging of the skin. It also relates to a cosmetic composition comprising queuine as an active ingredient.
    Type: Grant
    Filed: February 18, 2014
    Date of Patent: April 4, 2017
    Assignee: AMABIOTICS
    Inventors: Antoine Danchin, Agnieszka Sekowska
  • COSMETIC USE OF QUEUINE
    Publication number: 20160008252
    Abstract: The present invention relates to the cosmetic use of queuine, in particular to combat ageing of the skin. It also relates to a cosmetic composition comprising queuine as active ingredient.
    Type: Application
    Filed: February 18, 2014
    Publication date: January 14, 2016
    Inventors: ANTOINE DANCHIN, AGNIESZKA SEKOWSKA
  • NATURAL SELECTION AND CELLULAR IMMORTALITY
    Publication number: 20100062438
    Abstract: The invention provides new insights into the manner in which cells evolve and age thereby providing methods for assessing and studying those processes.
    Type: Application
    Filed: July 24, 2009
    Publication date: March 11, 2010
    Applicant: INSTITUT PASTEUR
    Inventor: Antoine DANCHIN
  • Process of Screening a Molecule as a Candidate Drug for the Treatment of Bipolar Disorder
    Publication number: 20100008894
    Abstract: The invention relates to a complex formed between the 3?-phosphoadenosine 5?-phosphate and polypeptide in human cells, to the use of pAp or of a molecule which mimics pAp for modulating the activity of poly(ADP-ribose)polymerase and small fragment nuclease in human cells, and to process of screening a molecule as a candidate drug for the treatment of diseases where modulation of at least one of the metabolic activities modulated by pAp is needed such as bipolar disorder or related diseases.
    Type: Application
    Filed: September 22, 2006
    Publication date: January 14, 2010
    Applicants: Institute pasteur, Centre National De Recherche Scientifique (CNRS)
    Inventors: Undine Mechold, Vasily Ogryzko, Antoine Danchin
  • Sequence of the photorhabdus luminescens strain tt01 genome and uses
    Publication number: 20070020625
    Abstract: The present invention relates to the genomic sequence and to nucleotide sequences encoding polypeptides of Photorhabdus luminescens. The present invention further relates to polypeptides involved in operons involved in the biosynthesis of antibiotics or toxins, as well as polypeptides with activity of the antibiotic or toxin. Uses of the aforementioned polypeptides in pesticides, bactericides, or fungicides is provides. In addition, the present invention provides vectors, cells, or animals containing the sequences of the present invention.
    Type: Application
    Filed: February 7, 2002
    Publication date: January 25, 2007
    Inventors: Eric Duchaud, Sead Taourit, Philippe Glaser, Lionel Frangeul, Frederik Kunst, Antoine Danchin, Carmen Buchrieser
  • Methionine salvage pathway in Bacillus
    Publication number: 20060182761
    Abstract: The present invention relates to pathways for the synthesis and recycling of methylthioribose (MTR), applications in the fight against plant and vertebrate pathogens (including parasites and their vectors), application for the production of fine chemicals, and in fermentation industry. The present invention also relates to the identification of new drug targets in previously unknown metabolic pathways in living organisms, in particular in bacteria, yeasts, mold, parasites and plants.
    Type: Application
    Filed: March 20, 2006
    Publication date: August 17, 2006
    Applicant: INSTITUT PASTEUR
    Inventors: Antoine Danchin, Agnieszka Sekowska
  • Microsporidian polar tube proteins, nucleic acids coding for these proteins and their applications
    Patent number: 6890536
    Abstract: This invention discloses purified complete microsporidian polar tube proteins and the proteins, the amino acid sequences of which are represented in the attached sequence listings as SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 4, SEQ ID No: 5. The invention discloses the genes coding these proteins and their use in the fields of diagnosis.
    Type: Grant
    Filed: January 5, 2001
    Date of Patent: May 10, 2005
    Inventors: Frédéric Delbac, Christian Vivares, Antoine Danchin
  • Methionine salvage pathway in bacillus
    Publication number: 20040019066
    Abstract: The present invention relates to pathways for the synthesis and recycling of methylthioribose (MTR), applications in the fight against plant and vertebrate pathogens (including parasites and their vectors), application for the production of fine chemicals, and in fermentation industry. The present invention also relates to the identification of new drug targets in previously unknown metabolic pathways in living organisms, in particular in bacteria, yeasts, mold, parasites and plants.
    Type: Application
    Filed: May 6, 2003
    Publication date: January 29, 2004
    Applicant: INSTITUT PASTEUR
    Inventors: Antoine Danchin, Agnieszka Sekowska
  • Microsporidian polar tube proteins, nucleic acids coding for these proteins and their applications
    Publication number: 20010021512
    Abstract: This invention discloses purified complete microsporidian polar tube proteins and the proteins, the amino acid sequences of which are represented in the attached sequence listings as SEQ ID No: 1, SEQ ID No: 2, SEQ ID No: 3, SEQ ID No: 4, SEQ ID No: 5. The invention discloses the genes coding these proteins and their use in the fields of diagnosis.
    Type: Application
    Filed: January 5, 2001
    Publication date: September 13, 2001
    Inventors: Frederic Delbac, Christian Vivares, Antoine Danchin
  • Adenyl cyclase derivatives and their biological uses
    Patent number: 5183745
    Abstract: The adenyl cyclase derivatives are atoxic derivatives in which one or several amino acids are different from those present in the toxic protein, the antibodies formed against these derivatives recognize, however, the toxic protein. These derivatives can be used as vaccines.
    Type: Grant
    Filed: October 25, 1989
    Date of Patent: February 2, 1993
    Assignee: Institut Pasteur
    Inventors: Antoine Danchin, Philippe Glaser, Evelyne Krin, Octavien Barzu, Daniel Ladant, Agnes Ullmann